Sun Pharma

Top Cyber Attacks that Shattered the Healthcare Industry in 2023 December 31, 2023 In this in-depth exploration, we delve into the chronology of these cyber threats, the reasons behind the healthcare sector becoming a target, and the pivotal role of cybersecurity in safeguarding India's digitising healthcare landscape.

Sun Pharma to Acquire 16.7% Stake in Lyndra Therapeutics for $30 Mn December 20, 2023 This strategic investment seeks to support the development of advanced pharmaceutical delivery technologies and get access to the technology for certain molecules and territories. Reportedly, the stake acquisition is expected to be completed by the end of December 2023.

Sun Pharma Inks Licencing Agreement with Zydus Lifesciences for Co-Marketing of CKD Related Novel Drug in India October 31, 2023 As per the agreement, Zydus has granted Sun Pharma semi-exclusive rights to co-market the product in India under the brand name RYTSTAT. While, Zydus has already been marketing this drug since 2022, under the brand name Oxemia and will further continue to market it.

Sun Pharma Inks Agreement With US-Based Pharmazz on Cerebral Ischemic Stroke Drug September 15, 2023 The Indian multinational pharmaceutical company, Sun Pharmaceutical has entered into a licence agreement with US-based Pharmazz Inc. to commercialise Tyvalzi (Sovateltide), in India.